PharmAla Closes Private Placement and Concurrent Debt Settlement
VANCOUVER, British Columbia, April 19, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: […]
AGBA/TRILLER $4 billion MERGER: ELEVATING SHAREHOLDER VALUE TO NEW HEIGHTS – IMMEDIATELY AND FOR THE LONG TERM
LOS ANGELES, April 19, 2024 (GLOBE NEWSWIRE) — NASDAQ-listed, AGBA Group Holding Limited (“AGBA”), has previously announced that on April […]
Collective Audience Appoints AdTech/MarTech Executive, Stacey Hawes, to Advisor Collective
NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) — Collective Audience, Inc. (Nasdaq: CAUD), a leading innovator of audience-based performance advertising […]
Lifeward Announces the Appointment of Mike Swinford to its Board of Directors
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 19, 2024 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (DBA Lifeward™) (Nasdaq: LFWD) (“Lifeward” or the […]
HUB Cyber Security Strongly Responds To Dominion’s Misleading Lawsuit; Reaffirms Dedication To Expansion And Worldwide Customer Support
TEL AVIV, Israel, April 19, 2024 (GLOBE NEWSWIRE) — via IBN — HUB Cyber Security Ltd. (Nasdaq: HUBC), a developer […]
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath
BERKELEY HEIGHTS, N.J., April 19, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and […]
La Rosa Regains Compliance with Nasdaq
Celebration, FL, April 19, 2024 (GLOBE NEWSWIRE) — La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a holding […]
Dave to Report First Quarter 2024 Results on May 7, 2024 at 8:30 a.m. ET
LOS ANGELES, April 19, 2024 (GLOBE NEWSWIRE) — Dave Inc. (“Dave” or the “Company”) (Nasdaq: DAVE), one of the nation’s […]
InterDigital Announces Date for First Quarter 2024 Financial Results
WILMINGTON, Del. , April 19, 2024 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research […]
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
NEW YORK, April 19, 2024 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its […]
